NanoRepro AG

NN6

Equity

ISIN DE0006577109 / Valor 4691951

Xetra (2026-01-22)

EUR 1.58+0.96%

NanoRepro AG
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

NanoRepro AG, based in Marburg, Germany, operates in the healthcare sector focusing on the development, manufacturing, and distribution of rapid diagnostic tests and food supplements. Since its public listing in October 2008, the company has positioned itself as a key player in the market for both home and professional use diagnostics. NanoRepro AG's product portfolio includes 24 CE-certified rapid diagnostic tests catering to a range of health concerns, including family planning, preventive healthcare, allergies, and infectious diseases. By offering these self-tests, NanoRepro aims to enhance the accessibility and accuracy of disease detection, facilitating timely health management. The company's commitment to innovation and quality reflects in its comprehensive range of products designed to meet the evolving healthcare needs of consumers worldwide.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

12.4%1Y

-32.8%3Y

-52.5%5Y

Performance

44.5%1Y

49.7%3Y

65.0%5Y

Volatility